{
    "clinical_study": {
        "@rank": "70484", 
        "arm_group": [
            {
                "arm_group_label": "Patients with lupus", 
                "description": "Patients with lupus (four levels of activity disease)"
            }, 
            {
                "arm_group_label": "healthy volunteers", 
                "description": "Subjects controls"
            }
        ], 
        "brief_summary": {
            "textblock": "Treatment of multisystemic forms of lupus displays severe side effects and limited efficacy,\n      underscoring the need to better dissection of the pathogenic mechanisms. Concordant with\n      preliminary data, IL26 signaling could be impaired in systemic lupus. Moreover, IL 26 could\n      be a marker of the disease activity and then a potential therapeutic target. In the present\n      study, serum IL 26 level in lupus patients and control will be measured."
        }, 
        "brief_title": "IL-26 and Systemic Lupus Erythematosus", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Diagnosis of Lupus According to ACR criteriaAgreement for the Blood Sampling", 
        "condition_browse": {
            "mesh_term": "Lupus Erythematosus, Systemic"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  diagnostic of Lupus according to ACR criteria ( four criteria are necessary)\n\n          -  age > 18 years old\n\n        Exclusion Criteria:\n\n          -  treatment by cyclophosphamide, rituximab, belimumab in the year before inclusion\n             study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "patient and healthy volunteers"
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01889641", 
            "org_study_id": "5504"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 14, 2014", 
        "location": {
            "contact": {
                "email": "audrey.gorse@chru-strasbourg.fr", 
                "last_name": "Audrey Gorse, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Strasbourg", 
                    "country": "France", 
                    "state": "Bas Rhin", 
                    "zip": "67091"
                }, 
                "name": "Les H\u00f4pitaux Universitaires de Strasbourg"
            }, 
            "investigator": [
                {
                    "last_name": "Audrey Gorse, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Catherine Mutter, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "2", 
        "official_title": "Int\u00e9r\u00eat de l'IL-26 Comme Nouveau Marqueur Biologique du Lupus \u00e9ryth\u00e9mateux syst\u00e9mique", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France : Agence national s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Assess serum IL-26 as a biological marker of SLE compared with sera from control subjects", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01889641"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University Hospital, Strasbourg, France", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Strasbourg, France", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}